New Psoriasis Drug

More on PSORIASIS ...
What Is Psoriasis?
Psoriasis is a chronic (long-lasting) skin disease of scaling and inflammation that affects 2 to 2.6 percent of the United States population, or between 5.8 and 7.5 million people. Although the disease occurs in all age groups, it primarily affects adults. It appears about equally in males and females. Psoriasis occurs when skin cells quickly rise from their origin below the surface of the skin and pile up on the surface before they have a chance to mature. Usually this movement (also called turnover) takes about a month, but in psoriasis it may occur in only a few days. In its typical form, psoriasis results in patches of thick, red (inflamed) skin covered with silvery scales. These patches, which are sometimes referred to as plaques, usually itch or feel sore. They most often occur on the elbows, knees, other parts of the legs, scalp, lower back, face, palms, and soles of the feet, but they can occur on skin anywhere on the body.

The disease (psoriasis) may also affect the fingernails, the toenails, and the soft tissues of the genitals and inside the mouth. While it is not unusual for the skin around affected joints to crack, approximately 1 million people with psoriasis experience joint inflammation that produces symptoms of arthritis. This condition is called psoriatic arthritis. - NIAMS

Top Resource Searches For:

New Psoriasis Drug

New Drug For Psoriasis
Breaking news on health topics for your family, finances, lifestyle, and business provided by applesforhealth.com, a healthy knowledge source. ... HospitalsChiropractorsEye DoctorsAlternate Health Prof.Drug InteractionsMedicationsDiseasesPoisonsInjuriesMental Health ... New Drug For Psoriasis. A new drug shows initial promise as a ...

Psoriasis drug gets new indication, warnings, dosing
HOME / TOP STORIES ARCHIVE / ARTICLE. TOP STORIES - ARTICLE. Psoriasis drug gets new indication, warnings, dosing. Acitretin has updated indication, more flexible dosing, but also new warning about depression, pregnancy.

National Psoriasis Foundation to Testify for Raptiva Approval
Password. News and Events. News. Federal Advisory Committee Recommends Approval of New Psoriasis Drug. Final approval could come by end of October. First posted Sept. 10, 2003. Last updated Sept. 23, 2003. In a unanimous vote on Sept. ... and Drug Administration (FDA) recommended approval of the psoriasis drug efalizumab (brand name Raptiva) for ...

HealthScout--New Psoriasis Drug Gains Approval
... Send to a Friend. New Psoriasis Drug Gains Approval ... A new drug to combat psoriasis has won approval from the U.S. Food and Drug Administration. ...

HON - News : Another New Drug for Psoriasis
... Another New Drug for Psoriasis. Efalizumb reduces reduces thick, red, scaly patches on skin ... "Biologics are a new approach to treating psoriasis. The symptom relief with biologics is ...

Genentech Says New Psoriasis Drug Batches Match Earlier Version
The biotech's study of a slightly different formula of Raptiva found no difference. ... Genentech Says New Psoriasis Drug Batches Match Earlier Version ... the FDA would complete a review of its new psoriasis drug, Amevive, within six months, slightly longer than many ...

MSNBC - FDA approves new psoriasis drug
... FDA approves new psoriasis drug. Raptiva should be available to consumers by Thanksgiving ... WASHINGTON - A new drug for the itchy-skin condition psoriasis won the Food and Drug ...

NBC 17 - Health Watch
The government wants to be ready if there's ever a massive flu outbreak -- but the biggest concern is the time it takes to make new vaccines. Full Story. In Depth: Flu Shots | Treatment. Are you ready to shed some pounds? ... Experts say a new blood pressure report shows Americans need to ... Illinois Drug Import Plan Concerns FDA ...

Psoriasis
... Lymphoma? - ABC News, 12/18/03. New Psoriasis Treatments Look Good - WebMD, 12/16/03 ... 11/10/03. New psoriasis drug wins FDA approval to use ...

Chronic Pain | New Psoriasis Drug